GoHealth Stock Forecast, Price & News

+0.05 (+0.44 %)
(As of 06/21/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume1.23 million shs
Average Volume1.58 million shs
Market Capitalization$3.64 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive GOCO News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

GoHealth logo

About GoHealth

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareÂInternal; MedicareÂExternal; Individual and Family Plans (IFP) and OtherÂInternal; and Individual and Family Plans and OtherÂExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carrier and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois.


Head-To-Head Survey: GoHealth (GOCO) & The Competition
Head-To-Head Survey: GoHealth (GOCO) & The Competition
June 21, 2021 |
Fun, On-the-Go Health Hacks - Yahoo Finance
Fun, On-the-Go Health Hacks - Yahoo Finance
June 21, 2021 |
Critical Analysis: GoHealth (GOCO) versus The Competition
Critical Analysis: GoHealth (GOCO) versus The Competition
June 20, 2021 |
Contrasting GoHealth (GOCO) & Its Rivals
Contrasting GoHealth (GOCO) & Its Rivals
June 20, 2021 |
GoHealth (GOCO) vs. Its Competitors Head to Head Review
GoHealth (GOCO) vs. Its Competitors Head to Head Review
June 19, 2021 |
Critical Comparison: GoHealth (GOCO) & The Competition
Critical Comparison: GoHealth (GOCO) & The Competition
June 19, 2021 |
Comparing GoHealth (GOCO) & The Competition
Comparing GoHealth (GOCO) & The Competition
June 14, 2021 |
GoHealth (GOCO) and Its Rivals Financial Survey
GoHealth (GOCO) and Its Rivals Financial Survey
June 14, 2021 |
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.79 out of 5 stars

Finance Sector

396th out of 1,980 stocks

Insurance Agents, Brokers, & Service Industry

10th out of 31 stocks

Analyst Opinion: 3.5Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

GoHealth (NASDAQ:GOCO) Frequently Asked Questions

Is GoHealth a buy right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last twelve months. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" GoHealth stock.
View analyst ratings for GoHealth
or view top-rated stocks.

What stocks does MarketBeat like better than GoHealth?

Wall Street analysts have given GoHealth a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but GoHealth wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting GoHealth?

GoHealth saw a decrease in short interest in May. As of May 28th, there was short interest totaling 4,450,000 shares, a decrease of 15.6% from the May 13th total of 5,270,000 shares. Based on an average daily trading volume, of 1,560,000 shares, the short-interest ratio is presently 2.9 days. Approximately 4.5% of the company's stock are short sold.
View GoHealth's Short Interest

When is GoHealth's next earnings date?

GoHealth is scheduled to release its next quarterly earnings announcement on Thursday, August 19th 2021.
View our earnings forecast for GoHealth

How were GoHealth's earnings last quarter?

GoHealth, Inc. (NASDAQ:GOCO) issued its quarterly earnings data on Wednesday, May, 12th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.01. The business had revenue of $204.20 million for the quarter, compared to analyst estimates of $176.41 million. GoHealth had a positive trailing twelve-month return on equity of 13.15% and a negative net margin of 2.70%. The business's revenue for the quarter was up 44.8% compared to the same quarter last year.
View GoHealth's earnings history

What guidance has GoHealth issued on next quarter's earnings?

GoHealth issued an update on its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $1.15 billion-1.30 billion, compared to the consensus revenue estimate of $1.21 billion.

What price target have analysts set for GOCO?

12 brokers have issued 12-month target prices for GoHealth's stock. Their forecasts range from $14.00 to $26.00. On average, they expect GoHealth's share price to reach $20.40 in the next twelve months. This suggests a possible upside of 79.9% from the stock's current price.
View analysts' price targets for GoHealth
or view top-rated stocks among Wall Street analysts.

Who are GoHealth's key executives?

GoHealth's management team includes the following people:
  • Mr. Brandon M. Cruz, Co-Founder, Co-Chair of the Board & Chief Strategy Officer (Age 43, Pay $1.75M)
  • Mr. Clinton P. Jones, Co-Founder, Co-Chair of the Board of Directors & CEO (Age 43, Pay $1.31M)
  • Mr. James A. Sharman, Pres (Age 62, Pay $862.24k)
  • Mr. Shane E. Cruz, Chief Operating Officer (Age 41, Pay $673.25k)
  • Mr. Travis J. Matthiesen, Chief Financial Officer (Age 37)
  • Ms. Ellen Wong, Chief Accounting Officer (Age 50)
  • Mr. Cem Varon, Chief Technology Officer
  • Mr. Jason Koval, VP of Investor Relations
  • Mr. Brian P. Farley, Chief Legal Officer & Corp. Sec. (Age 51)
  • Mr. Jarret Ditoro, Chief Marketing Officer

What is Matthew Crummack's approval rating as GoHealth's CEO?

25 employees have rated GoHealth CEO Matthew Crummack on Matthew Crummack has an approval rating of 90% among GoHealth's employees.

Who are some of GoHealth's key competitors?

What other stocks do shareholders of GoHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GoHealth investors own include Tesla (TSLA), Alibaba Group (BABA), CVS Health (CVS), Honeywell International (HON), Moderna (MRNA), Raytheon Technologies (RTX), Walmart (WMT), Cisco Systems (CSCO), Intel (INTC) and Johnson & Johnson (JNJ).

When did GoHealth IPO?

(GOCO) raised $750 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 39,500,000 shares at a price of $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley served as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

What is GoHealth's stock symbol?

GoHealth trades on the NASDAQ under the ticker symbol "GOCO."

Who are GoHealth's major shareholders?

GoHealth's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (1.78%), River Road Asset Management LLC (1.68%), Credit Suisse AG (1.53%), BlackRock Inc. (1.37%), The Manufacturers Life Insurance Company (0.67%) and Millennium Management LLC (0.62%). Company insiders that own GoHealth stock include Anita Pramoda, Shane E Cruz and Travis J Matthiesen.
View institutional ownership trends for GoHealth

Which major investors are selling GoHealth stock?

GOCO stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Holocene Advisors LP, Squarepoint Ops LLC, Alyeska Investment Group L.P., Prana Capital Management LP, Schonfeld Strategic Advisors LLC, Price T Rowe Associates Inc. MD, and Blair William & Co. IL. Company insiders that have sold GoHealth company stock in the last year include Shane E Cruz, and Travis J Matthiesen.
View insider buying and selling activity for GoHealth
or view top insider-selling stocks.

Which major investors are buying GoHealth stock?

GOCO stock was bought by a variety of institutional investors in the last quarter, including River Road Asset Management LLC, The Manufacturers Life Insurance Company, Millennium Management LLC, BlackRock Inc., CWM LLC, Cannell Capital LLC, Credit Suisse AG, and Goldman Sachs Group Inc..
View insider buying and selling activity for GoHealth
or or view top insider-buying stocks.

How do I buy shares of GoHealth?

Shares of GOCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GoHealth's stock price today?

One share of GOCO stock can currently be purchased for approximately $11.34.

How much money does GoHealth make?

GoHealth has a market capitalization of $3.64 billion and generates $877.35 million in revenue each year. The company earns $-44,270,000.00 in net income (profit) each year or $2.51 on an earnings per share basis.

How many employees does GoHealth have?

GoHealth employs 3,067 workers across the globe.

What is GoHealth's official website?

The official website for GoHealth is

Where are GoHealth's headquarters?

GoHealth is headquartered at 214 WEST HURON STREET, CHICAGO IL, 60654.

How can I contact GoHealth?

GoHealth's mailing address is 214 WEST HURON STREET, CHICAGO IL, 60654. The company can be reached via phone at 312 386 8200 or via email at [email protected]

This page was last updated on 6/22/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.